Clinical Trial Update: Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing adjuvant Vinorelbine plus Cisplatin (NP) versus NP plus Endostar in patients with completely resected stage IB-IIIA non-small cell lun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Endostar (recombinant human endostatin)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED